Skip to main content

HIND

Vyome Holdings, Inc

Company with tickers: HIND

Market Cap
$15.16M
Shares Outstanding
7,018,528
CIK
1427570
CUSIP
92943X104

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Line Item Value
Revenue $31,591
Revenue (ASC 606)
Interest & Dividend Income
Net Interest Income
Noninterest Income
Total Net Revenue
Premiums Earned (Net)
Cost of Revenue
Gross Profit $16,645
Operating Expenses $1,146,585
Research & Development $666,405
Operating Income $-1,129,940
Net Income $-962,910
EPS (Basic) $-0.15
EPS (Diluted) $-0.15

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

By Segment (USD)

Component 2023-12-31 2024-12-31 2025-12-31
Pharmaceutical $256,944 $319,714
Single Reportable Segment $8,678,000

By Geography (USD)

Component 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
United States $8,275,000 $10,297,000 $9,230,000 $7,134,000 $6,887,000
Europe $1,824,000 $2,127,000 $1,252,000 $956,000 $687,000
Australia $1,086,000 $1,039,000 $688,000 $526,000 $392,000
Non Us $114,000 $137,000 $70,000 $62,000 $40,000

By Product & Service (USD)

Component 2024-12-31 2025-12-31
Product $134,395 $174,645
License $116,900
Royalty $47,402 $28,169
Service $75,147